Table 3.
Regional distribution volume (VT) estimates from the three different methods for each of the groups. Data are expressed as mean ± SD for the tracer dose group (n = 10) and as individual values for the pre-saturated group (n = 2)
VT | |||
---|---|---|---|
Region | 2TCM | 1TCM | SA |
Tracer dose (n = 10) | |||
Frontal cortex | 7.81 ± 1.10 | 7.80 ± 2.38 | 7.15 ± 1.17 |
Hippocampus | 6.86 ± 0.94 | 6.84 ± 2.08 | 6.55 ± 0.95 |
Cerebellum* | 4.44 ± 0.67 | 4.11 ± 1.24 | 4.33 ± 0.65 |
Medulla* | 2.77 ± 0.48 | 2.35 ± 0.71 | 2.66 ± 0.39 |
Pons* | 2.54 ± 0.40 | 2.10 ± 0.61 | 2.45 ± 0.33 |
Pre-saturated (n = 2) | |||
Frontal cortex | 1.23 and 1.10 | 0.67 and 0.73 | 1.00 and 0.89 |
Hippocampus | 1.07 and 0.92 | 0.60 and 0.62 | 1.09 and 0.68 |
Cerebellum | 0.98 and 0.91 | 0.52 and 0.58 | 1.00 and 0.69 |
Medulla | 0.89 and 0.80 | 0.46 and 0.56 | 0.69 and 0.83 |
Pons | 0.99 and 0.88 | 0.55 and 0.59 | 0.80 and 0.72 |
*Significant differences were found in these regions between 1TCM and 2TCM estimates (p < 0.005) as well as between 1TCM and SA (p < 0.05)